Literature DB >> 19871319

THE MULTIPLICATION OF BACTERIOPHAGE IN VIVO AND ITS PROTECTIVE EFFECT AGAINST AN EXPERIMENTAL INFECTION WITH SHIGELLA DYSENTERIAE.

R J Dubos1, J H Straus, C Pierce.   

Abstract

1. Anti-Shiga bacteriophage injected into the general circulation can multiply in the brain of mice infected intracerebrally with Shigella dysenteriae. 2. Under proper conditions, the injection of active bacteriophage into the general circulation can protect mice against an otherwise fatal intracerebral infection with Shigella dysenteriae. 3. The protection so induced appears to depend upon the early establishment of a high bacteriophage level in the infected animal.

Entities:  

Year:  1943        PMID: 19871319      PMCID: PMC2135327          DOI: 10.1084/jem.78.3.161

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  Bacteriophagy in the Developing Chick Embryo.

Authors:  T L Rakieten; M L Rakieten
Journal:  J Bacteriol       Date:  1943-05       Impact factor: 3.490

  1 in total
  28 in total

1.  Phage as an antimicrobial agent: d'Herelle's heretical theories and their role in the decline of phage prophylaxis in the West.

Authors:  Dottore Emiliano Fruciano; Shawna Bourne
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-01       Impact factor: 2.471

2.  Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model.

Authors:  Quintin F Wills; Claire Kerrigan; James S Soothill
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves.

Authors:  P Barrow; M Lovell; A Berchieri
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

Review 4.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

Review 5.  Therapeutic and prophylactic applications of bacteriophage components in modern medicine.

Authors:  Sankar Adhya; Carl R Merril; Biswajit Biswas
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

6.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

7.  Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15.

Authors:  Flavie Pouillot; Maryline Chomton; Hélène Blois; Celine Courroux; Julien Noelig; Philippe Bidet; Edouard Bingen; Stéphane Bonacorsi
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

8.  Phage Therapy - Everything Old is New Again.

Authors:  Andrew M Kropinski
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

9.  Propionibacterium acnes bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates.

Authors:  Laura J Marinelli; Sorel Fitz-Gibbon; Clarmyra Hayes; Charles Bowman; Megan Inkeles; Anya Loncaric; Daniel A Russell; Deborah Jacobs-Sera; Shawn Cokus; Matteo Pellegrini; Jenny Kim; Jeff F Miller; Graham F Hatfull; Robert L Modlin
Journal:  MBio       Date:  2012-09-25       Impact factor: 7.867

10.  Bacteriophages for managing Shigella in various clinical and non-clinical settings.

Authors:  Lawrence D Goodridge
Journal:  Bacteriophage       Date:  2013-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.